Summary
- Current Price
- As of today, NGNE price is $19.05, down -0.73% on
- Current Price All-Time High
- NGNE price is currently -98.29% below its historical high of $1,115.00 set on
- Market Cap
- NGNE current market cap is $295M, up +39.09% over the past 365 days
- PE Ratio
- NGNE PE ratio is unknown
- Revenue
- NGNE current annual revenue is $925.00K, up +100.00% year-over-year
- Next Earnings
- The next earnings release for NGNE is on
Profile
| Metric | Value |
|---|---|
| Full Name | Neurogene Inc. |
| Ticker | NASDAQ: NGNE |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | neurogene.com |
| Employees | 107 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $19.05 | ||
| Price, 1D Change | -0.73% | |
| $295M | ||
| - | ||
| - | ||
| 1.93 | ||
| $925K | ||
| Revenue, 1Y Change | +100.00% | |
| -$4.28 | ||
| EPS, 1Y Change | -51.05% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:4 | |
| Next Split | N/A | N/A |
| Last Ticker Change | NLTX | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$4.28 | ||
| EPS Estimate | -$4.28 | |
| EPS Est. Change | -0.06% | |
| $925.00K | ||
| Revenue Estimate | - | |
| Revenue Est. Change | - | |
| $19.05 | ||
| Price Target | - | $60.00 |
| Price Tgt. Change | - | +214.96% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$5.58 | -$2.83 | +49.25% | |
| -$3.86 | -$4.28 | -10.82% | |
| -$4.28 | N/A | -0.06% | |
| -$4.94 | N/A | -15.54% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| $770.83K | $925.00K | +20.00% | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +34.06% | ||
| +52.40% | ||
| +39.09% | ||
| +1,002.64% | ||
| +100.00% | ||
| +100.00% | ||
| -51.05% | ||
| -287.92% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $19.05 | ||
| $21.29 | ||
| SMA 200 vs Price | +11.76% | |
| $19.24 | ||
| SMA 50 vs Price | +1.01% | |
| 1.93 | ||
| $1.79 | ||
| 43.29 | ||
| 56.20% | ||
| 109.33% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $925.00K | ||
| -$4.28 | ||
| -$2.32M | ||
| -251.03% | ||
| -$82.61M | ||
| -8,930.27% | ||
| -$75.14M | ||
| -8,123.68% | ||
| -$79.36M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.04 | ||
| 20.84 | ||
| 20.84 | ||
| - | ||
| - | ||
| 5.97 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 1.11 | ||
| -0.42 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $310.38M | ||
| $312.41M | ||
| $336.44M | ||
| $315.92M | ||
| $26.07M | ||
| $15.16M | ||
| $12.43M | ||
| $3.00M | ||
| $1.34M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $76.07M | ||
| $80.28M | ||
| $3.25M | ||
| $0.00 | ||
| $3.20M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$70.60M | ||
| -$125.26M | ||
| $184.07M | ||
| $808.00K | ||
| -$71.41M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Canaccord Genuity | ||
| LifeSci Capital | ||
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Craig-Hallum | ||
| BMO Capital | → | |
| BMO Capital | → | |
| Baird | → |
Analyst sentiment
Institutional ownership
Screeners with NGNE
FAQ
What is the ticker symbol for Neurogene Inc.?
The ticker symbol for Neurogene Inc. is NASDAQ:NGNE
Does Neurogene Inc. pay dividends?
No, Neurogene Inc. does not pay dividends
What sector is Neurogene Inc. in?
Neurogene Inc. is in the Healthcare sector
What industry is Neurogene Inc. in?
Neurogene Inc. is in the Biotechnology industry
What country is Neurogene Inc. based in?
Neurogene Inc. is headquartered in United States
When did Neurogene Inc. go public?
Neurogene Inc. initial public offering (IPO) was on March 7, 2014
Is Neurogene Inc. in the S&P 500?
No, Neurogene Inc. is not included in the S&P 500 index
Is Neurogene Inc. in the NASDAQ 100?
No, Neurogene Inc. is not included in the NASDAQ 100 index
Is Neurogene Inc. in the Dow Jones?
No, Neurogene Inc. is not included in the Dow Jones index
When was Neurogene Inc. last earnings report?
Neurogene Inc.'s most recent earnings report was on November 13, 2025
When does Neurogene Inc. report earnings?
The next expected earnings date for Neurogene Inc. is March 23, 2026
Data Sources & References
- NGNE Official Website www.neurogene.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1404644/000140464425000101/0001404644-25-000101-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1404644/000140464425000012/0001404644-25-000012-index.htm
- NGNE Profile on Yahoo Finance finance.yahoo.com/quote/NGNE
- NGNE Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ngne